Results 61 to 70 of about 3,193 (201)

Manejo de la enfermedad de von Willebrand en ginecología y obstetricia: Revisión cualitativa de la literatura A qualitative review of the literature regarding managing Von willebrand disease in obstetrics and gynaecology

Revista Colombiana de Obstetricia y Ginecología, 2010
Introducción: la enfermedad de Von Willebrand es el trastorno de la coagulación con mayor prevalencia de mujeres en edad fértil y, por lo tanto, es el trastorno genético de la hemostasia más frecuente en la práctica ginecológica y obstétrica.
Franklin J Espitia-De La Hoz
doaj  

Oral Soft Tissue Biopsy in Patients Receiving Direct Oral Anticoagulants: A Prospective Cohort Study on Bleeding Outcomes

Oral Diseases, EarlyView.
ABSTRACT Background Direct oral anticoagulants (DOACs) are the first‐line therapy for stroke prevention in non‐valvular atrial fibrillation and venous thromboembolism. While evidence supports their continuation during routine dental procedures such as tooth extractions, data on oral soft tissue biopsies remain limited.
Rossana Izzetti, Chiara Cinquini, Antonio Barone, Marco Nisi   +3 more
wiley   +1 more source

Antifibrinolytics in a rural trauma state: assessing the opportunities

Trauma Surgery & Acute Care Open, 2017
Background Tranexamic acid (TXA) has demonstrated improved mortality among trauma patients. However, recent evidence from urban US trauma centers has failed to show a benefit among the civilian population. TXA in rural states has not been evaluated. This
Alison Wilson, Amanda Palmer, James M Bardes, Jorge Con, Gregory Schaefer   +4 more
doaj   +1 more source

Prioritising parameters to minimise blood transfusions for postpartum haemorrhage: A machine learning study using national population data

Transfusion Medicine, EarlyView.
Abstract Background Postpartum haemorrhage (PPH) accounts for approximately 27% of maternal deaths worldwide and often requires blood transfusion, along with its associated risks. In resource‐rich settings like South Korea, transfusion disparities persist, highlighting the need for predictive tools to optimise patient blood management (PBM).
Ki Hoon Ahn, Yu‐Min Choi, Kwang‐Sig Lee   +2 more
wiley   +1 more source

Just one thing to reduce bleeding: Put tranexamic acid on the safe surgical checklist at your hospital

Transfusion Medicine, EarlyView.
Abstract Objectives To highlight tranexamic acid (TXA) as ‘just one thing’ that every hospital could implement to reduce surgical bleeding and blood transfusions. Background TXA is a low‐cost antifibrinolytic agent that inhibits the breakdown of fibrin blood clots. Developed in Japan in the 1960s, it has been shown to reduce surgical bleeding.
Ian Roberts, Katharine Ker
wiley   +1 more source

Alternativas farmacológicas a la transfusión sanguínea: ¿Qué hay de nuevo? [PDF]

, 2004
Pharmacological approaches to reduce blood transfusion include the protease inhibitor aprotinin, lysine-analogue antifibrinolytics synthetic arginine-vasopressin derivatives (DDAVP) and recombinant factor VII (rfVIIa).
Milagros Hernández, Eduardo Rocha, Hernandez, M. (Milagros), Lecumberri, R. (Ramón), Rocha, E. (Eduardo), Paramo, J.A. (José Antonio), José A Páramo, Ramón Lecumberri   +7 more
core   +1 more source

Quality without a mandate: An exploratory national survey of perioperative autologous transfusion accreditation barriers

Transfusion, EarlyView.
Abstract Background Perioperative autologous transfusion, encompassing intraoperative cell salvage (ICS), acute normovolemic hemodilution (ANH), and autologous component production, is integral to patient blood management. Association for the Advancement of Blood and Biotherapies (AABB) has published comprehensive quality standards, yet perioperative ...
Gagan Mathur, Nada Naiyer, Patricia Travassos, Jennifer O'Brien, Tonya Nuelle, Allan Klompas, Muharrem Yunce, David Moolten   +7 more
wiley   +1 more source

Inhaled tranexamic acid as a treatment option in nonmassive hemoptysis: a randomized controlled trial

Egyptian Journal of Chest Disease and Tuberculosis
Background Hemoptysis is a potentially life-threatening condition with variable etiology and severity. Tranexamic acid (TXA), an antifibrinolytic agent, has demonstrated efficacy in bleeding control.
Eman A.A. Ali, Mohamed M. El-Gamal, Manal M.R. Algharbawy   +2 more
doaj   +1 more source

Inter‐institutional perspectives on usage of fibrinogen replacement therapies in North America

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Cryoprecipitated antihemophilic factor (cryoprecipitate), fibrinogen concentrate (FC), and pathogen‐reduced cryoprecipitated fibrinogen complex (PR cryoprecipitate) are sources of fibrinogen replacement, and each has advantages and disadvantages in terms of cost, efficacy, safety, and logistics of administration. This
Cindy Tay, Laura K. Dilly, Wen Lu, Kerry O'Brien, Hlaing Tint, Quentin Eichbaum   +5 more
wiley   +1 more source

Neutrophil Extracellular Traps Block Fibrinolysis in Ischemic Stroke

Annals of Neurology, Volume 100, Issue 5, Page 964-978, November 2026.
Objectives Intravenous thrombolysis (IVT) failure in acute ischemic stroke (AIS) is frequent, but its causes remain elusive. We investigated whether biologically relevant intrathrombus concentrations of tissue plasminogen activator (tPA) were achieved in failed IVT and whether neutrophil extracellular traps (NETs) contributed to this therapeutic ...
Mialitiana Solo Nomenjanahary, Jean‐Philippe Desilles, Fatima Zemali, Astride Perrot, Lucas Di Meglio, Sara Zalghout, Jéromine Fasille, Jérémy Neel, Stéphane Loyau, Julien Labreuche, Marie‐Charlotte Bourrienne, Dorothée Faille, François Delvoye, Véronique Ollivier, Sébastien Dupont, Jasmina Rogozarski, Nahida Brikci‐Nigassa, Robert L. Medcalf, Nadine Ajzenberg, Mikael Mazighi, Benoît Ho‐Tin‐Noé, the compoCLOT Study Group   +21 more
wiley   +1 more source